Enhanced stereochemistry (ABS / OR / AND): old vs. new InChI

old: InChI dev (fbf1e01), default options. new: InChI atropisomers (3e5b496), -EnhancedStereochemistry. The changed part of the new InChI is in red. Small grey numbers in the pictures: canonical atom numbers of the new InChI (per component). Collection labels abs, orn, andn. Molecule IDs are shared by all specs. Generated by tools/build.py.

Enhanced stereochemistry (ABS / OR / AND) (30)

Explanation for chemists
How the new InChI is built: step by step, with examples from this table

IDMoleculeInChI
1molecule 1(S)-butan-2-ol, ABS group
oldInChI=1S/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
newInChI=1B/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
2molecule 2butan-2-ol, OR group: one enantiomer, unknown which
oldInChI=1S/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
newInChI=1B/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/s2
3molecule 3butan-2-ol, AND group: racemate
oldInChI=1S/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
newInChI=1B/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/s3
4molecule 4ungrouped wedge = absolute
oldInChI=1S/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
newInChI=1B/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
5molecule 5two centres, one OR group (relative configuration)
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/s2
6molecule 6two centres, one AND group (racemic diastereomer)
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/s3
7molecule 7two independent OR groups
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/s2(2)(3)
8molecule 8two independent AND groups
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/s3(2)(3)
9molecule 9ABS + OR
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/m1/s1(2)2(3)
10molecule 10ABS + AND
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/m1/s1(2)3(3)
11molecule 11OR + AND
oldInChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
newInChI=1B/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/s2(2)3(3)
12molecule 12three classes: ABS, OR, AND
oldInChI=1S/C5H10BrClO/c1-3(6)5(7)4(2)8/h3-5,8H,1-2H3/t3-,4+,5+/m0/s1
newInChI=1B/C5H10BrClO/c1-3(6)5(7)4(2)8/h3-5,8H,1-2H3/t3-,4-,5-/m1/s1(4)2(5)3(3)
13molecule 13edge: meso-tartaric acid in an AND group
oldInChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2+
newInChI=1B/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2+
14molecule 14trans-1,2-dimethylcyclohexane, OR group
oldInChI=1S/C8H16/c1-7-5-3-4-6-8(7)2/h7-8H,3-6H2,1-2H3/t7-,8-/m1/s1
newInChI=1B/C8H16/c1-7-5-3-4-6-8(7)2/h7-8H,3-6H2,1-2H3/t7-,8-/s2
15molecule 15edge: ungrouped wedge beside an OR group
oldInChI=1S/C6H13ClO/c1-5(7)3-4-6(2)8/h5-6,8H,3-4H2,1-2H3/t5-,6+/m0/s1
newInChI=1B/C6H13ClO/c1-5(7)3-4-6(2)8/h5-6,8H,3-4H2,1-2H3/t5-,6-/m0/s2(6)
16molecule 16two components, one OR group each
oldInChI=1S/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/m00/s1
newInChI=1B/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/s2
17molecule 17two components, both absolute: uniform /s
oldInChI=1S/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/m10/s1
newInChI=1B/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/m10/s1
18molecule 18edge: AND group spanning two components (dropped)
oldInChI=1S/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/m00/s1
newInChI=1B/C5H12O.C4H10O/c1-3-4-5(2)6;1-3-4(2)5/h5-6H,3-4H2,1-2H3;4-5H,3H2,1-2H3/t5-;4-/m00/s1
19molecule 19edge: centre chiral only by isotope (ethanol-1-d), AND
oldInChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3/i2D/t2-/m0/s1
newInChI=1B/C2H6O/c1-2-3/h3H,2H2,1H3/i2D/t2-/s3
20molecule 20edge: ABS label on a CH2 (not a stereocentre)
oldInChI=1S/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/m0/s1
newInChI=1B/C4H10O/c1-3-4(2)5/h4-5H,3H2,1-2H3/t4-/s3
21molecule 21ibuprofen, racemate
oldInChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m1/s1
newInChI=1B/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/s3
22molecule 22thalidomide, racemate
oldInChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/t9-/m1/s1
newInChI=1B/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/t9-/s3
23molecule 23ephedrine, relative configuration (OR)
oldInChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1
newInChI=1B/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/s2
24molecule 24BIOVIA white paper, Fig. 22
oldInChI=1S/C24H34N2O3/c1-13-6-4-7-17(14(13)2)22-19-11-10-16(18-8-5-9-21(27)23(18)28)12-20(19)26-24(29)15(3)25-22/h10-15,17-18,21,23,27-28H,4-9H2,1-3H3,(H,26,29)/t13-,14-,15+,17+,18+,21-,23+/m0/s1
newInChI=1B/C24H34N2O3/c1-13-6-4-7-17(14(13)2)22-19-11-10-16(18-8-5-9-21(27)23(18)28)12-20(19)26-24(29)15(3)25-22/h10-15,17-18,21,23,27-28H,4-9H2,1-3H3,(H,26,29)/t13-,14-,15-,17-,18-,21-,23+/m1/s1(15)2(13,14)(21,23)3(17)(18)
25molecule 25cyclosporin, AND group (OpenChemLib)
oldInChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1
newInChI=1B/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/s3
26molecule 26two AND groups (RDKit)
oldInChI=1S/C16H22N2O4/c19-14-10-21-9-13(14)18-16(20)17-8-12-6-7-15(22-12)11-4-2-1-3-5-11/h1-5,12-15,19H,6-10H2,(H2,17,18,20)/t12-,13+,14-,15+/m0/s1
newInChI=1B/C16H22N2O4/c19-14-10-21-9-13(14)18-16(20)17-8-12-6-7-15(22-12)11-4-2-1-3-5-11/h1-5,12-15,19H,6-10H2,(H2,17,18,20)/t12-,13-,14+,15+/s3(12,15)(13,14)
27molecule 27OR and AND groups (Indigo)
oldInChI=1S/C10H12INO2/c1-7(9(12-11)10(13)14)8-5-3-2-4-6-8/h2-7,9,12H,1H3,(H,13,14)/t7-,9+/m0/s1
newInChI=1B/C10H12INO2/c1-7(9(12-11)10(13)14)8-5-3-2-4-6-8/h2-7,9,12H,1H3,(H,13,14)/t7-,9-/s2(9)3(7)
28molecule 28OR enantiomer (Ketcher)
oldInChI=1S/C5H10N2O/c1-4-5(6)7-2-3-8-4/h4H,2-3H2,1H3,(H2,6,7)/t4-/m0/s1
newInChI=1B/C5H10N2O/c1-4-5(6)7-2-3-8-4/h4H,2-3H2,1H3,(H2,6,7)/t4-/s2
29molecule 29ChEMBL record, OR only (CDPKit)
oldInChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15-/m0/s1
newInChI=1B/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15-/s2
30molecule 30EOS49757, ABS only
oldInChI=1S/C15H19N3O3/c1-17-11(7-8-16-17)10-12-4-3-9-18(12)15(19)13-5-6-14(20-2)21-13/h5-8,12H,3-4,9-10H2,1-2H3/t12-/m0/s1
newInChI=1B/C15H19N3O3/c1-17-11(7-8-16-17)10-12-4-3-9-18(12)15(19)13-5-6-14(20-2)21-13/h5-8,12H,3-4,9-10H2,1-2H3/t12-/m0/s1

Meso compounds: groups that change nothing (8)

Explanation for chemists

IDMoleculeInChI
108molecule 108trans-cyclohexane-1,4-diol (achiral), no group
oldInChI=1S/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
newInChI=1B/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
109molecule 109same, AND group: ignored
oldInChI=1S/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
newInChI=1B/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
110molecule 110same, OR group: ignored
oldInChI=1S/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
newInChI=1B/C6H12O2/c7-5-1-2-6(8)4-3-5/h5-8H,1-4H2/t5-,6-
111molecule 111meso butane-2,3-diol, one AND group: ignored
oldInChI=1S/C4H10O2/c1-3(5)4(2)6/h3-6H,1-2H3/t3-,4+
newInChI=1B/C4H10O2/c1-3(5)4(2)6/h3-6H,1-2H3/t3-,4+
112molecule 112chiral butane-2,3-diol, one AND group: racemate, kept
oldInChI=1S/C4H10O2/c1-3(5)4(2)6/h3-6H,1-2H3/t3-,4-/m1/s1
newInChI=1B/C4H10O2/c1-3(5)4(2)6/h3-6H,1-2H3/t3-,4-/s3
113molecule 113chiral by side chain, no group
oldInChI=1S/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s1
newInChI=1B/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s1
114molecule 114limitation: AND group on the meso ring only (should be ignored)
oldInChI=1S/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s1
newInChI=1B/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s3(9,10)
115molecule 115limitation: OR group on the meso ring only (should be ignored)
oldInChI=1S/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s1
newInChI=1B/C10H21NO2/c1-8(11)6-7-13-10-4-2-9(12)3-5-10/h8-10,12H,2-7,11H2,1H3/t8-,9-,10-/m1/s2(9,10)